Washington. SEER uses the Collaborative Stage (CS) Data Collection System. We have retained the SEER CS variables. There was a significant relationship of income with breast cancer incidence in 50 USA states and the District of Columbia in White women (r = 0.623, p < 0.001). There was a significant relationship between node involvement and income in Whites in 198 USA counties. Income was significantly correlated with 5-year relative survival in Whites with localized breast cancer. Income was not correlated with 5-year survival of Black race (p = 0.364) or other races (p = 0.624). The multivariate general linear model with income as covariate, 5-year survival by race as a dependent variable, showed a significant effect of income and White race on 5-year survival (p < 0.001), unrelated to Black race (p = 0.780) or other races (p = 0.618). In men, we found a nonsignificant positive correlation between county breast cancer incidence and income (r = 0.098, p = 0.168). Breast cancer risk factors, such as delayed childbirth, less breast-feeding, and use of hormone supplements, are more common in affluent women. Affluent women are more likely to have mammograms, which detect many cancers that might not otherwise be diagnosed. In addition, women in certain affluent ethnic groups-Ashkenazi Jews, Icelanders and the Dutch-are more likely to carry genetic mutations known to predispose to breast cancer. We hypothesize that women with more income can afford better cancer care and survive longer than poorer women. But our hypothesis does not explain why this effect should be limited to White women; or why node involvement increased with income in White women but not in Blacks or Hispanics. Further studies may be worthwhile. n
H igh income, high socioeconomic status, and affluence increase breast cancer incidence. Madigan et al. reported that women in the upper two-thirds of the USA population by income had an age-adjusted breast cancer risk of 1.7, while in the lower third their risk was not elevated (1) . In Marin County, north of San Francisco, the median per capita income is more than twice as high as that of the USA as a whole, and between 1990 and 1999 Marin County breast cancer incidence increased six times more rapidly than in comparison areas (2) . However, a study of women in San Francisco suggested that affluence increases breast cancer incidence only in Hispanic women (3) . In addition, breast cancer incidence is increasing in lower income countries (4, 5) .
Socioeconomic status in USA breast cancer studies has been assessed by block-group socioeconomic measures. A block group is a portion of a census tract with boundaries that segregate, as far as possible, socioeconomic groups (3) . Income data, an excellent mark of socioeconomic status, is not recorded in the National Cancer Institute's Surveillance, Epidemiology and End Results Program (SEER) data base or other cancer registries (6) .
In this study, we used U.S. Census income data instead of block groups to gauge socioeconomic status of breast cancer patients in relationship with incidence, prognostic markers, and survival. 
METHODS

RESULTS
There was a significant relationship of income with breast cancer incidence in 50 USA states and the District of Columbia in White women (r = 0.623, p < 0.001, Fig. 1 ). The relationship of income to incidence was not significant in Black women (r = À0.176, p = 0.221) and is of borderline significance in Hispanics (r = 0.277, p = 0.051). There was no significant correlation of income with mortality (deaths per 100,000) in Whites (r = 0.172, p = 0.227), Blacks (r = À0.154, p = 0.393), or Hispanics (r = À0.042, p = 0.867). Multivariate linear regression indicated that the relationship with income of breast cancer incidence in White women was significant (b = 0.371, p = 0.001) and independent of the relationship with alcohol consumption (b = 0.518, p < 0.001).
There was a significant relationship between node involvement and income in Whites in 198 USA counties (Fig. 2) . The multivariate general linear model with income as covariate, node involvement by race as dependent variable, showed a significant effect of Although income was not significantly correlated with mortality, as noted above, income was significantly correlated with a 5-year relative survival in Whites with localized breast cancer (p < 0.001, Fig. 3 ). Localized means breast cancer localized to the breast, not involving the nodes. Income was not correlated with a 5-year survival of Black race (p = 0.364) or other races (p = 0.624). The multivariate general linear model with income as covariate, 5-year survival by race as a dependent variable, showed a significant effect of income and White race on a 5-year survival (p < 0.001), unrelated to Black race (p = 0.780) or other races (p = 0.618).
In men, we found a nonsignificant positive correlation between SEER county breast cancer incidence and income (r = 0.098, p = 0.168).
DISCUSSION
Breast cancer has generally been considered a disease of affluence, possibly because risk factors. such as delayed childbirth, less breast-feeding, and use of hormone supplements. are more common in affluent women. Affluent women are more likely to have mammograms, which detect many cancers that might not otherwise be diagnosed. In addition, women in certain affluent ethnic groups-Ashkenazi Jews, Icelanders and the Dutch-are more likely to carry genetic mutations that predispose to breast cancer. Nevertheless, breast cancer mortality is higher in Black women than White women (6, 15) .
Alcohol is a well-documented breast cancer risk factor, probably due to increased estrogens and androgens, as well as a direct carcinogenic effect on breast tissue (16) . Drinking at least two glasses of wine a day (or the equivalent alcohol) is correlated with both affluence and higher breast cancer risk. But we found that the relationship with income of breast cancer incidence in White women was independent of the relationship with alcohol consumption.
In Figure 2 , the four outliers are from Hawaii County, Honolulu County, Kauai County, and Maui County. Meng et al. report that native Hawaiian and Filipino women have a higher risk of dying from breast cancer within 5 years than women of other ethnic groups (17) . The elevated incidence of nodes in affluent women would correspond to the elevated mortality, especially if some of the native Hawaiian and Filipino women were classified as White in SEER, even though SEER includes a designation for Asian-Pacific Islanders.
As was mentioned, cancer registries do not contain breast cancer incidence data and corresponding socioeconomic status data as defined by income. Our analysis based on income confirms the relationship of breast cancer incidence to affluence but only in White women, not Blacks, and a borderline relationship in Hispanics.
Ansell found that income was associated with a relative risk of death in breast cancer of 1.6 and that this effect was marginally significant (p = 0.06) in a multivariate analysis including Black race, estrogen receptor, distant disease, and age (18) . In contrast, we found that income increases 5-year survival, but only in White women. We were not able to include therapy (radiation versus not, systemic therapy versus not), stage, and/or tumor size/grade in a multivariate analysis because of SEERstat limitations.
We hypothesize that women with more income can afford better cancer care and survive longer than poorer women. But our hypothesis does not explain why this effect should be limited to White women; or why node involvement increased with income in White women but not in Blacks or Hispanics.
One expects that affluence will correlate positively with improved access to screening and healthcare. Yet we arrived at the contradictory conclusions that affluent women, although more likely to be screened, are more likely to have node -positive disease, yet more likely to have improved 5-year survival compared to other groups. Obviously, a highly screened population will have a higher incidence of node positivity, since more attention to the patient and more elaborate screening techniques are more likely to detect nodes than the simple axillary palpation afforded to low income patients. Moreover, better access to care and better care given to affluent women can no doubt overcome the 5-year survival disadvantage of nodepositive disease. Nevertheless, further studies may be worthwhile.
